Red blood cell dysfunction induced by high-fat diet: Potential implications for obesity-related atherosclerosis

Circulation

Volumn 132, Issue 20, 2015, Pages 1898-1908

  Unruh, Dusten ^a   Srinivasan, Ramprasad ^a   Benson, Tyler ^b   Haigh, Stephen ^b   Coyle, Danielle ^a,c   Batra, Neil ^a   Keil, Ryan ^a   Sturm, Robert ^a   Blanco, Victor ^a   Palascak, Mary ^a   Franco, Robert S ^a   Tong, Wilson ^a   Chatterjee, Tapan ^b   Hui, David Y ^a   Davidson, W Sean ^a   Aronow, Bruce J ^a   Kalfa, Theodosia ^a   Manka, David ^a,d   Peairs, Abigail ^c   Blomkalns, Andra ^e   Fulton, David J ^b   Brittain, Julia E ^f   Weintraub, Neal L ^b   Bogdanov, Vladimir Y ^a   more..

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d HemoShear LLC   (United States)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

^f NONE

Author keywords

atherosclerosis; erythrocytes; leukocytes; obesity

Indexed keywords

CHEMOKINE; CHOLESTEROL; LIPID; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLSERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ERYTHROCYTE; ERYTHROCYTE DISORDER; GENE EXPRESSION; LIPID DIET; MACROPHAGE; MACROPHAGE MIGRATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPLEEN; WILD TYPE; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHAGOCYTOSIS; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; DIET, HIGH-FAT; ERYTHROCYTES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; PHAGOCYTOSIS;

EID: 84947485313     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.017313     Document Type: Article

References (40)

1. Bornfeldt KE, Tabas I, Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab 2011 14 575 585. doi: 10.1016/j.cmet.2011.07.015
2. Osborn O, Olefsky JM, The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012 18 363 374. doi: 10.1038/nm.2627
3. Gower RM, Wu H, Foster GA, Devaraj S, Jialal I, Ballantyne CM, Knowlton AA, Simon SI, CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol 2011 31 160 166. doi: 10.1161/ATVBAHA.110.215434
4. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ, Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 2007 117 195 205. doi: 10.1172/JCI29950
5. Rothe G, Herr AS, Stöhr J, Abletshauser C, Weidinger G, Schmitz G, A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease. Atherosclerosis 1999 144 251 261
6. Schnabel RB, Baumert J, Barbalic M, Dupuis J, Ellinor PT, Durda P, Dehghan A, Bis JC, Illig T, Morrison AC, Jenny NS, Keaney JF Jr, Gieger C, Tilley C, Yamamoto JF, Khuseyinova N, Heiss G, Doyle M, Blankenberg S, Herder C, Walston JD, Zhu Y, Vasan RS, Klopp N, Boerwinkle E, Larson MG, Psaty BM, Peters A, Ballantyne CM, Witteman JC, Hoogeveen RC, Benjamin EJ, Koenig W, Tracy RP, Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood 2010 115 5289 5299. doi: 10.1182/blood-2009-05-221382
7. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R, Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003 349 2316 2325. doi: 10.1056/NEJMoa035655
8. Virmani R, Roberts WC, Extravasated erythrocytes, iron, and fibrin in atherosclerotic plaques of coronary arteries in fatal coronary heart disease and their relation to luminal thrombus: frequency and significance in 57 necropsy patients and in 2958 five mm segments of 224 major epicardial coronary arteries. Am Heart J 1983 105 788 797
9. Barber LA, Palascak MB, Joiner CH, Franco RS, Aminophospholipid translocase and phospholipid scramblase activities in sickle erythrocyte subpopulations. Br J Haematol 2009 146 447 455. doi: 10.1111/j.1365-2141.2009.07760.x
10. Hanahan DJ, Ekholm JE, The preparation of red cell ghosts (membranes). Methods Enzymol 1974 31 168 172
11. Fukuma N, Akimitsu N, Hamamoto H, Kusuhara H, Sugiyama Y, Sekimizu K, A role of the Duffy antigen for the maintenance of plasma chemokine concentrations. Biochem Biophys Res Commun 2003 303 137 139
12. Bäck M, Weber C, Lutgens E, Regulation of atherosclerotic plaque inflammation (published online ahead of print March 30 2015). J Intern Med. doi: 10.1111/joim.12367. http://onlinelibrary.wiley.com/doi/10.1111/joim.12367/abstract;jsessionid=38ECD3970FD682FDD1B00D94734862E9.f04t03. Accessed October 12, 2015
13. Hansell CA, Hurson CE, Nibbs RJ, DARC and D6: silent partners in chemokine regulation? Immunol Cell Biol 2011 89 197 206. doi: 10.1038/icb.2010.147
14. Emanuele E, Falcone C, D'Angelo A, Minoretti P, Buzzi MP, Bertona M, Geroldi D, Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease. Atherosclerosis 2006 186 140 145. doi: 10.1016/j.atherosclerosis.2005.07.002
15. Rousselle A, Qadri F, Leukel L, Yilmaz R, Fontaine JF, Sihn G, Bader M, Ahluwalia A, Duchene J, CXCL5 limits macrophage foam cell formation in atherosclerosis. J Clin Invest 2013 123 1343 1347. doi: 10.1172/JCI66580
16. Döring Y, Pawig L, Weber C, Noels H, The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease. Front Physiol 2014 5 212. doi: 10.3389/fphys.2014.00212
17. Dasgupta SK, Abdel-Monem H, Guchhait P, Nagata S, Thiagarajan P, Role of lactadherin in the clearance of phosphatidylserine-expressing red blood cells. Transfusion 2008 48 2370 2376. doi: 10.1111/j.1537-2995.2008.01841.x
18. Hale JP, Winlove CP, Petrov PG, Effect of hydroperoxides on red blood cell membrane mechanical properties. Biophys J 2011 101 1921 1929. doi: 10.1016/j.bpj.2011.08.053
19. Hardeman MR, Ince C, Clinical potential of in vitro measured red cell deformability, a myth? Clin Hemorheol Microcirc 1999 21 277 284
20. Grau M, Pauly S, Ali J, Walpurgis K, Thevis M, Bloch W, Suhr F, RBC-NOS-dependent S-nitrosylation of cytoskeletal proteins improves RBC deformability. PLoS One 2013 8 e56759. doi: 10.1371/journal.pone.0056759
21. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, Weissleder R, Pittet MJ, Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009 325 612 616. doi: 10.1126/science.1175202
22. Price JE, Barth RF, Johnson CW, Staubus AE, Injection of cells and monoclonal antibodies into mice: comparison of tail vein and retroorbital routes. Proc Soc Exp Biol Med 1984 177 347 353
23. Dijkstra CD, Van Vliet E, Döpp EA, van der Lelij AA, Kraal G, Marginal zone macrophages identified by a monoclonal antibody: characterization of immuno-and enzyme-histochemical properties and functional capacities. Immunology 1985 55 23 30
24. Safeukui I, Buffet PA, Deplaine G, Perrot S, Brousse V, Ndour A, Nguyen M, Mercereau-Puijalon O, David PH, Milon G, Mohandas N, Quantitative assessment of sensing and sequestration of spherocytic erythrocytes by the human spleen. Blood 2012 120 424 430. doi: 10.1182/blood-2012-01-404103
25. Wallace FA, Neely SJ, Miles EA, Calder PC, Dietary fats affect macrophage-mediated cytotoxicity towards tumour cells. Immunol Cell Biol 2000 78 40 48. doi: 10.1046/j.1440-1711.2000.00867.x
26. Kleemann R, Zadelaar S, Kooistra T, Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 2008 79 360 376. doi: 10.1093/cvr/cvn120
27. Vita JA, Endothelial function. Circulation 2011 124 e906 e912. doi: 10.1161/CIRCULATIONAHA.111.078824
28. Davis N, Katz S, Wylie-Rosett J, The effect of diet on endothelial function. Cardiol Rev 2007 15 62 66. doi: 10.1097/01.crd.0000218824.79018.cd
29. Hui DY, Harmony JA, Interaction of plasma lipoproteins with erythrocytes. I. Alteration of erythrocyte morphology. Biochim Biophys Acta 1979 550 407 424
30. Cooper RA, Abnormalities of cell-membrane fluidity in the pathogenesis of disease. N Engl J Med 1977 297 371 377. doi: 10.1056/NEJM197708182970707
31. Koter M, Broncel M, Chojnowska-Jezierska J, Klikczynska K, Franiak I, The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia. Eur J Clin Pharmacol 2002 58 501 506. doi: 10.1007/s00228-002-0507-9
32. Jilma-Stohlawetz P, Homoncik M, Drucker C, Marsik C, Rot A, Mayr WR, Seibold B, Jilma B, Fy phenotype and gender determine plasma levels of monocyte chemotactic protein. Transfusion 2001 41 378 381
33. Barger AC, Beeuwkes R 3rd, Lainey LL, Silverman KJ, Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984 310 175 177. doi: 10.1056/NEJM198401193100307
34. Matsuzawa-Nagata N, Takamura T, Ando H, Nakamura S, Kurita S, Misu H, Ota T, Yokoyama M, Honda M, Miyamoto K, Kaneko S, Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 2008 57 1071 1077. doi: 10.1016/j.metabol.2008.03.010
35. Connor J, Pak CC, Schroit AJ, Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 1994 269 2399 2404
36. Rezende AB, Neto NN, Fernandes LR, Ribeiro AC, Alvarez-Leite JI, Teixeira HC, Splenectomy increases atherosclerotic lesions in apolipoprotein E deficient mice. J Surg Res 2011 171 e231 e236. doi: 10.1016/j.jss.2011.08.010
37. Kennedy A, Gruen ML, Gutierrez DA, Surmi BK, Orr JS, Webb CD, Hasty AH, Impact of macrophage inflammatory protein-1α deficiency on atherosclerotic lesion formation, hepatic steatosis, and adipose tissue expansion. PLoS One 2012 7 e31508. doi: 10.1371/journal.pone.0031508
38. Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM, Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol 1996 16 1000 1006
39. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M, Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2003 23 656 660. doi: 10.1161/01.ATV.0000064374.15232.C3
40. Ordovas-Montanes JM, Ordovas JM, Cholesterol, Inflammasomes, and Atherogenesis. Curr Cardiovasc Risk Rep 2012 6 45 52. doi: 10.1007/s12170-011-0212-2